FundedIQ

Funded Startups in Sherman Oaks

Among the 9 Sherman Oaks entries shown, the largest disclosed round is Ketchup Entertainment’s $100M on 2026-05-11, which dwarfs most other disclosed amoun…

Among the 9 Sherman Oaks entries shown, the largest disclosed round is Ketchup Entertainment’s $100M on 2026-05-11, which dwarfs most other disclosed amounts in this set (e.g., $150M for Forte Biosciences on 2026-04-08 is the top disclosed figure, and $110M for FloQast on 2021-07-21 is the next-largest shown). The date distribution is also concentrated toward the present: 6 of 9 rounds fall between 2023-09-07 (Crystal Sonic) and the most recent 2026-06-12 (Pacific Consulting Group), with multiple large checks clustering in spring 2026 (Tetrous on 2026-04-21 for $2M; Forte Biosciences on 2026-04-08 for $150M; Ketchup Entertainment on 2026-05-11 for $100M). Sector-wise, “Series Unknown” appears in 5 of 9 entries, while disclosed smaller rounds and one “undisclosed” amount (Sanguine on 2023-01-09) sit beside two very large biotech/financial-services checks ($150M Forte Biosciences; $110M FloQast).

Most recent rounds

9 shown

Related listings

Frequently asked

What stands out as the largest disclosed round in Sherman Oaks, and how extreme is it versus the rest of the disclosed amounts?

Forte Biosciences’ disclosed $150M round on 2026-04-08 is the top figure in this list, materially above the next-largest disclosed amounts: FloQast’s $110M on 2021-07-21 and Ketchup Entertainment’s $100M on 2026-05-11. Aside from those, most other disclosed rounds are far lower (for example, Pacific Consulting Group’s $3M on 2026-06-12 and Tetrous’ $2M on 2026-04-21).

Are these Sherman Oaks rounds clustered in time, or spread evenly across years?

They skew recent in this view: 6 of 9 rounds are dated from 2023-09-07 (Crystal Sonic) through 2026-06-12 (Pacific Consulting Group). Within that window, spring 2026 is especially concentrated with Forte Biosciences (2026-04-08, $150M), Tetrous (2026-04-21, $2M), and Ketchup Entertainment (2026-05-11, $100M).

Which stage labels dominate, and what does that imply about how “defined” the financing types are in this set?

“Series Unknown” appears in 5 of 9 entries (Pacific Consulting Group, Ketchup Entertainment, Tetrous, Forte Biosciences, and Crystal Sonic), with the remaining 4 split across defined labels like Series A (homium, 2024-04-16, $10M), Series D (FloQast, 2021-07-21, $110M), and Grant (Exceptional Minds, 2022-10-23, $1M). That mix suggests financing stage is frequently not disclosed in the rows shown.

Are any sectors over-represented in these 9 Sherman Oaks entries?

No single sector repeats in 3+ entries. The highest concentration is “one each” across sectors such as Biotechnology (Forte Biosciences, $150M on 2026-04-08), Financial Services (FloQast, $110M on 2021-07-21), Apps (Sanguine, 2023-01-09, undisclosed), and Information Technology (homium, $10M on 2024-04-16).

Do any outliers suggest different risk/traction profiles than the rest (based on disclosed amounts and sectors)?

Yes: the biotech/large-check pattern is an outlier versus the smaller disclosed rounds, with Forte Biosciences at $150M (2026-04-08) and Tetrous at $2M (2026-04-21) arriving within weeks in the same city. Another outlier is the financial-services scale check from FloQast at $110M (2021-07-21), while the smallest disclosed amount is $850K for Crystal Sonic (2023-09-07).

Which entries use undisclosed funding, and does that affect comparisons to the smallest disclosed round?

Only one row shows “undisclosed” amount: Sanguine on 2023-01-09 (Apps, Sherman Oaks). Comparisons to the smallest disclosed figure still hold for disclosed rows: Crystal Sonic’s $850K on 2023-09-07 is the smallest disclosed amount shown, but Sanguine’s actual size is not inferable from the table.

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.